| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_MMP10_0000100 | Intergenic-Exon | chr11:102641233-102650092 | chr11:102770502-102779361 | 1375 nt | 0.4247 |
| hsa_MMP10_0000200 | Intergenic-Exon | chr11:102641233-102650476 | chr11:102770502-102779745 | 1617 nt | 0.4304 |
| hsa_MMP10_0000400 | Exon-Exon | chr11:102643578-102650476 | chr11:102772847-102779745 | 1121 nt | 0.4567 |
| hsa_MMP10_0000300 | Exon-Exon | chr11:102642743-102650476 | chr11:102772012-102779745 | 1225 nt | 0.4547 |
A review of circular RNAs in human diseases consolidates findings that the circMMP10 is not specifically discussed in the provided literature, which instead details numerous other circRNAs with altered expression in various cancers, neurological disorders, and cardiovascular conditions [Lee et al. DOI:10.1016/j.biopha.2018.12.052]. The literature extensively documents the role of circRNAs as miRNA sponges, regulators of transcription and translation, and their potential as clinical biomarkers in biofluids like blood and saliva [Suresh L. Mehta et al. DOI:10.1016/j.pneurobio.2020.101746]. A study in humans demonstrated that the circular RNA (circRNA) form of MMP10, a menstrual blood-specific biomarker, was detectable in all menstrual blood samples and exhibited high specificity [Liu et al. DOI:10.1016/J.Fsigen.2020.102312].